Cargando…
Multi-organ FGF21-FGFR1 signaling in metabolic health and disease
Metabolic syndrome is a chronic systemic disease that is particularly manifested by obesity, diabetes, and hypertension, affecting multiple organs. The increasing prevalence of metabolic syndrome poses a threat to public health due to its complications, such as liver dysfunction and cardiovascular d...
Autores principales: | Kaur, Namrita, Gare, Sanskruti Ravindra, Shen, Jiahan, Raja, Rida, Fonseka, Oveena, Liu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378980/ https://www.ncbi.nlm.nih.gov/pubmed/35983184 http://dx.doi.org/10.3389/fcvm.2022.962561 |
Ejemplares similares
-
FGF21/FGFR1-β-KL cascade in cardiomyocytes modulates angiogenesis and inflammation under metabolic stress()
por: Kaur, Namrita, et al.
Publicado: (2023) -
The multifaceted roles of ER and Golgi in metabolic cardiomyopathy
por: Raja, Rida, et al.
Publicado: (2022) -
Cellular Protein Quality Control in Diabetic Cardiomyopathy: From Bench to Bedside
por: Kaur, Namrita, et al.
Publicado: (2020) -
The Roles and Pharmacological Effects of FGF21 in Preventing Aging-Associated Metabolic Diseases
por: Yan, Junbin, et al.
Publicado: (2021) -
Indoxyl sulfate induces left ventricular hypertrophy via the AhR-FGF23-FGFR4 signaling pathway
por: Kishimoto, Hiroshi, et al.
Publicado: (2023)